$ 0.37
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
In Guru Portfolios
Data is available to registered users only
Data is available to registered users only
Portfolio Weight (%)
Data is available to registered users only
Change
Data is available to registered users only
Fund
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Portfolio Weight (%)
Data is available to registered users only
Change
Data is available to registered users only
Fund
Data is available to registered users only
Data is available to registered users only
Data is available to registered users only
Portfolio Weight (%)
Data is available to registered users only
Change
Data is available to registered users only
Fund
Data is available to registered users only
Manager | Fund | Portfolio Weight (%) | Change |
|---|---|---|---|
Data is available to registered users only | Data is available to registered users only | Data is available to registered users only | Data is available to registered users only |
Data is available to registered users only | Data is available to registered users only | Data is available to registered users only | Data is available to registered users only |
Data is available to registered users only | Data is available to registered users only | Data is available to registered users only | Data is available to registered users only |
About
Medicus Pharma Ltd., a biotechnology and life sciences enterprise, is dedicated to expediting the progression of innovative and groundbreaking medical treatments through their clinical development phases. A primary focus for the company is the creation of non-surgical solutions specifically targeting dermatological malignancies.
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers.
Data is available to registered users only